Auvi Labs, Inc. — SEC Form D Filing
Auvi Labs, Inc. filed an SEC Form D on August 26, 2026, reporting $442K raised in Medical Devices.
Form D filing details
- Filing
- SEC Form D
- Filing date
- August 26, 2026
- Amount reported
- $442K
- Industry
- Medical Devices
- Website
- https://auvilabs.com/
What the company does
Securities: Debt. Exemption: Rule 506(b). Incorporated: DELAWARE
Problem
Hemodialysis patients experience a high rate of vascular access failure, which is a significant clinical challenge.
Solution
Auvi Labs develops a wearable ultrasound device specifically designed to detect vascular access failure.
Verdict
This cleared because the solution directly addressed a known, high-cost clinical failure point with a tangible, portable device, not because it promised a broad platform shift. Investors were implicitly betting on the company's ability to navigate medical device regulatory pathways and execute on a focused product launch within a specialized market. The limited upside came from the niche nature of the initial application, suggesting a constrained market size without clear expansion pathways beyond hemodialysis.
Source: SEC EDGAR Form D filing